Genzyme Asks Fed. Circ. To Revive Muscle Treatment Patents
Genzyme Therapeutic Products made a final push Thursday to convince the Federal Circuit to reverse a decision that invalidated claims in two patents covering methods of treating a muscle disease, insisting...To view the full article, register now.
Already a subscriber? Click here to view full article